Revolution Medicines, Inc.
Revolution Medicines, Inc. (RVMD) Stock Overview
Explore Revolution Medicines, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
19.6B
P/E Ratio
-16.66
EPS (TTM)
$-5.95
ROE
-0.63%
RVMD Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Revolution Medicines, Inc. (RVMD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 54.26, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $92.17.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -16.66 and a market capitalization of 19.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.